edited by James A. de Lemos
Biomarkers in Heart Disease covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years.
Biomarkers in Heart Disease aims at meeting the needs of:
- clinicians
- providing cardiologists
- internists
- emergency physicians
- laboratorians
- other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine
Contents
- Protocols for diagnosing myocardial infarction
- Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes
- Challenges interpreting cardiac troponin values
- Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease
- Novel markers in patients with suspected acute coronary syndromes
- Use of natriuretic peptides in the diagnosis of heart failure
- Biomarkers for risk stratification in patients with heart failure
- Natriuretic peptides for disease monitoring in patients with chronic heart failure
- C-Reactive Protein
- Newer markers for population screening: focus on lipoprotein-related markers
- Moving toward personalized medicine
Index